characterization of proteins which are subject to posttranslational modification.
An extensive panel of mycobacterial proteins involved in recognition by the host immune system has been identified by biochemical fractionation or by screening of recombinant DNA expression libraries (reviewed in reference 32). Several of these antigens have been proposed as potential targets for improved diagnostic tests or for incorporation into novel subunit vaccines, but difficulties in obtaining sufficient quantities of the purified reagents have impeded comparative experimental testing of such suggestions (13, 30, 32) . In addition to the requirement for strict containment facilities, pathogenic mycobacteria grow very slowly (Mycobacterium tuberculosis doubling time, 24 h) or not at all (Mycobacterium leprae) in laboratory culture, presenting significant practical obstacles to large-scale growth for biochemical fractionation. For some antigens, members of conserved heat shock protein families, for example, these problems have been overcome by high-level expression of the relevant genes in standard Escherichia coli recombinant DNA systems (18, 27) . Several other antigens have been expressed as fusion proteins in E. coli but have proved difficult to overexpress as free proteins (9, 17, 29) . This latter class includes proteins containing signal sequences or other features indicative of a requirement for posttranslational modification (6, 8, 17, 30, 31) . It is attractive to speculate that a mycobacterial host may provide the optimal system for expression of such antigens.
The recent development of techniques and vectors for transformation of mycobacteria (14, 21, 23, 24) has been stimulated by the goal of creating a new generation of recombinant Mycobacterium bovis BCG vaccines (1, 14, 25) .
In addition to the utility of such systems for expressing a range of heterologous antigens from other unrelated pathogens, the same approach is also convenient for transferring genes between mycobacterial species. It has been demonstrated, for example, that genes encoding the superoxide dismutase enzymes of M. leprae and M. tuberculosis are expressed from their own promoters in Mycobacterium smegmatis (a rapid-growing species suitable for laboratory manipulation), while provision of an exogenous promoter was essential for expression of the same genes in E. coli (26, 33) . In addition, it was found that the mycobacterial system allowed expression of functionally active superoxide dismutase, in contrast to the enzymatically inactive recombinant product in E. coli (33) . In the present study, we have examined the use of a mycobacterial expression system to facilitate the immunological characterization of a 19-kDa antigen from M. tuberculosis. The 19-kDa antigen was originally identified by using a set of murine monoclonal antibodies binding to M. tuberculosis and a limited number of nontuberculous mycobacteria (5) and was subsequently shown to elicit both humoral and cell-mediated immune responses in mice and patients with tuberculosis (7, 9, 13) . Results from nucleotide sequence analysis (2) and biochemical characterization of the 19-kDa antigen (31) suggest that the mature protein is secreted across the cell membrane and is present as a lipoprotein in M. tuberculosis. Similarly, posttranslational acylation of the corresponding protein from Mycobacterium avium-intracellulare has been suggested (20) , and analysis of the 19-kDa antigen purified from M. bovis has provided evidence of glycosylation (8) . The Protein extracts were prepared from M. tuberculosis harvested from plates and disrupted in distilled water by using glass beads as described previously (13) . The total protein concentration was estimated by using a protein assay system supplied by Bio-Rad Laboratories (Richmond, Calif.) with bovine serum albumin (BSA) as the standard. E. coli JM105 (Pharmacia) and TG1 (22) were grown on Luria-Bertani medium with 50 Wg of kanamycin sulfate per ml added as described by Sambrook et al. (22) . pBAK-7q is a derivative of pBAK14, a shuttle plasmid capable of replicating in mycobacteria and in E. coli (33) , containing a recombinant 1.8-kb SmaI fragment which includes the structural gene encoding the M. tuberculosis 19-kDa antigen (2, 9) . DNA manipulation. Plasmid DNA was prepared by standard procedures and analyzed by restriction enzyme digestion and agarose gel electrophoresis as described by Sambrook et al. (22) . Transformation of M. smegmatis with shuttle plasmids was carried out by electroporation as described previously (33) . E. coli was transformed by using standard methods (22) .
Gel electrophoresis and Western blotting (immunoblotting). Electrophoresis in polyacrylamide gels containing sodium dodecyl sulfate (SDS-PAGE) and blotting onto nitrocellulose membranes was carried out by using standard procedures (15, 28) . Samples used for Western blot analysis contained 0.3 to 3 ,ug of total protein. Antigens were stained on nitrocellulose membranes by using monoclonal antibodies specific for the 19-kDa antigen, namely, TB23 (3, 5) , HYT6 (5) , and F29-47 (5), by using techniques described previously (33) . Quantitative analysis of Western blots was carried out by using a Shimadzu CS-9000 dual-wavelength, flying-spot scanning densitometer at 550 nm. Results are expressed in terms of peak area as relative absorbance units.
The procedures for staining of nitrocellulose blots with peroxidase-conjugated concanavalin A (ConA) were essentially identical to those used for antibody staining. Nonspecific binding was blocked by incubating blots for 1 h with 4% (wt/vol) BSA in phosphate-buffered saline (PBS) with Triton X-100 (0.2%, vol/vol). After repeated washes with PBS and PBS-Triton X-100, the blots were incubated with 20 ml of ConA-peroxidase conjugate (0.2 purpurogallin units per ml; Sigma) in 2% (wt/vol) BSA in PBS-Triton X-100 for 1 h. After further washing, blots were stained for peroxidase activity by adding 3,3'-diaminobenzidine HCI and hydrogen peroxide in PBS.
Purification of the recombinant 19-kDa antigen. The recombinant 19-kDa antigen was purified by a novel procedure based on exploitation of its relative insolubility in urea and subunit molecular weight. M. smegmatis 1-2c transformed with pBAK-7q was grown at 37°C for 4 days in six 2-liter conical flasks containing 500 ml of Middlebrook 7H9-glucose medium with 50 ,ug of kanamycin sulfate per ml in a rotary incubator at 150 rpm. Bacteria were pelleted for 10 min at 10,000 x g, resuspended in 50 ml of water, and sonicated for a total of 10 min (MSE Soniprep 150, 19-mm probe, at maximum output). Cell debris was removed by centrifugation for 10 min at 16,000 x g, and the supernatant was centrifuged at 48,000 x g overnight at 20°C. The resulting pellet was resuspended in 10 ml of water, urea was added at 480 mg/ml, and the suspension was rolled overnight at 4°C. After centrifugation at 230,000 x g for 3 h at 20°C, a turbid pellet was obtained on top of a much-larger, translucent, reddish-brown pellet. The upper, turbid, pellet was resuspended in 8 M urea to a final volume of 25 ml and centrifuged for a further 3 h at 230,000 x g. The turbid grey pellet was resuspended in a minimum volume of 8 M urea and then diluted 1:10 in water and centrifuged for 3 h at 13,000 rpm (Sorvall, GSA rotor). The resulting pellet was resuspended overnight at 4°C in an equal volume of 50 mM Tris HCl (pH 8.0) containing 2% (vol/vol) Triton X-100 and 5 mM EDTA.
After centrifugation for 3 h at 27,000 x g, the resulting white pellet was resuspended in 5 ml of 50 mM Tris HCl (pH 8.0) containing 5% SDS and 10% 3-mercaptoethanol and held on a boiling water bath for 5 min. The sample was centrifuged at 10,000 x g for 10 min at 4°C, and the supernatant (with 10% sucrose added) was loaded onto a Biogel P-100 gel bed (2.6 by 100 cm; Bio-Rad) equilibrated with 50 mM Tris HCl (pH 8.0)-1% SDS-1% 3-mercaptoethanol. The 19-kDa antigen eluted between 137 and 153 ml.
Antigens and synthetic peptides for T-cell assays. A heatkilled preparation of M. tuberculosis H37Ra was obtained from Difco. A recombinant protein consisting of the M. tuberculosis 19-kDa antigen fused to glutathione S-transferase (rGST19) was expressed in E. coli and isolated as described in detail elsewhere (9) . A synthetic peptide, p19.7, corresponding to residues 61 to 80 of the M. tuberculosis 19-kDa antigen (VTGSVVCITAAGNVNIAIGG), was synthesized by simultaneous solid-phase multiple-peptide technology as previously described (9).
Murine T-celi line. A CD4+ murine T-cell line specific for the M. tuberculosis 19-kDa antigen was generated as follows. C57BV10 mice were immunized in the hind footpads with a total of 50 ,ug of rGST19 emulsified in incomplete Freund's adjuvant. Seven days later, the draining popliteal lymph node cells were removed, and single-cell suspensions were prepared in complete tissue culture medium (RPMI-1640 medium supplemented with 5% fetal calf serum [GIBCO, Paisley, Scotland], 5 x 10' M P-mercaptoethanol, 2 mM L-glutamine, 100 U of penicillin per ml, and 100 ,g of streptomycin sulfate per ml). Primed lymph node cells were cultured in 24-well plates (Nunc, Roskilde, Denmark) at a concentration of 4 x 106 cells per well in the presence of 20 ,ug of rGST19 per ml. After 6 days, viable cells were recovered by centrifugation over Ficoll gradients and recultured at a concentration of 0.5 x 106 cells per well together with 3 x 106 irradiated syngeneic spleen cells as antigenpresenting cells. After 5 days of rest, 0.5 x 106 cells per well were restimulated in the presence of irradiated antigenpresenting cells and 20 ,ug of rGST19 per ml. A stable cell line was maintained by the same cycles of rest and restimulation for more than 6 months.
T-celi proliferation assays. Proliferation assays with the rGST19 T-cell line were performed at the end of a resting cycle. T cells ( (29) .
Proliferation assays with intact mycobacteria. For use in T-cell proliferation assays, M. smegmatis was harvested from the logarithmic phase of growth and washed with sterile PBS. The bacterial count was estimated on the basis of A600, and samples (corresponding to 105 to 107 CFU/ml) were either added directly to T-cell proliferation assays or first killed by heating for 20 min at 60°C. Cultures were incubated for 3 days, and proliferation was assessed by incorporation of radiolabelled thymidine as described above. The addition of live M. smegmatis did not result in any significant increase in thymidine incorporation; it is likely that the presence of streptomycin sulfate in the medium was sufficient to inhibit bacterial multiplication during the assay.
RESULTS
Expression of the 19-kDa antigen in M. smegmatis. The gene encoding the 19-kDa antigen of M. tuberculosis was excised from pRL19k2.8 (2, 9) by digestion with SmaI, generating a 1.8-kb fragment containing the structural gene flanked by approximately 0.9 (5') and 0.4 (3') kb of additional DNA. The SmaI fragment was inserted into the ScaI site of the mycobacterial shuttle vector pBAK14 to prepare pBAK-7q (Fig. 1) . pBAK-7q was introduced into E. coli JM105, and a small-scale plasmid preparation was used to transform M. smegmatis 1-2c. Extracts from E. coli and M. smegmatis recombinants were screened for antigen expression by Western blot analysis (Fig. 2) (Fig. 2) . To compare the level of expression of the recombinant 19-kDa antigen in M. smegmatis with that in M. tuberculosis, samples containing various amounts of total protein were analyzed by Western blotting by using two different monoclonal antibodies, and the results were quantitated by use of a scanning densitometer (Fig. 3) Carbohydrate associated with the 19-kDa antigen. A low level of expression of the 19-kDa antigen was detected by immunoblot of E. coli transformed with pBAK-7q. We noted that the antigen expressed in E. coli migrated with a different apparent molecular weight during SDS-PAGE than that of the native M. tuberculosis antigen and the recombinant M. smegmatis product (Fig. 4A) . This molecular mass difference, corresponding to approximately 4 kDa, was most apparent when extracts from the two recombinant strains were combined and run in a single lane on the gel (Fig. 4A,  lane 2) . A further difference was noted when blots were stained with peroxidase-conjugated ConA, a lectin specific for t-D-mannose and a-D-glucose, for detection of carbohydrate residues. This procedure highlighted a number of [11, 12] ) demonstrated the presence of some LAM in purified antigen preparations but did not detect any LAM associated with the 19-kDa band on SDS-PAGE (data not shown).
T-cell recognition of the recombinant 19-kDa antigen. A murine T-cell line specific for the M. tuberculosis 19-kDa antigen was generated to investigate the immunological activity of the recombinant antigen expressed in M. smegmatis. The antigenic specificity of this line was confirmed by strong in vitro proliferative responses to rGST19 and to a peptide (p19.7, residues 61 to 80) containing the major murine T-cell epitope in the M. tuberculosis 19-kDa antigen (9) . The T-cell line also responded vigorously to the 19-kDa protein expressed in M. tuberculosis, whereas M. smegmatis failed to induce a significant proliferative response (Fig.  5A ). The lack of response to M. smegmatis is consistent with serological evidence indicating that M. smegmatis does not express a protein with antigenic cross-reactivity to the M. tuberculosis 19-kDa antigen (3, 5, 10) . After transformation with pBAK-7q, however, M. smegmatis extracts induced a strong response and were four to five times more potent in T-cell proliferation assays than M. tuberculosis H37Rv extracts (Fig. 5B) .
The recombinant 19-kDa antigen was also efficiently presented for T-cell recognition when added to the assay in the form of intact bacteria. Proliferative responses were induced by both live and killed M. smegmatis/pBAK-7q, while the control M. smegmatis/pBAK14 failed to stimulate significant responses (Fig. 6A) . Inhibitory effects resulting from the addition of crude extracts of M. smegmatis to T-cell proliferation assays were found to be less severe than those observed with comparable E. coli extracts. The response of the T-cell line to the purified 19-kDa antigen was inhibited by 50% after the addition of 1 to 2 ,ug of protein from an E. coli sonicate, for example, while approximately 30 ,ug of protein from an equivalent M. smegmatis extract was required to induce the same inhibitory effect (Fig. 6B) .
Purification of the recombinant 19-kDa antigen. The recombinant 19-kDa antigen was further characterized by biochemical fractionation. Like the native antigen in M. tuberculosis, the recombinant 19-kDa protein was found mainly in the pellet fraction generated by high-speed centrifugation of bacterial extracts (Fig. 2) . For protein purification, extracts from M. smegmatislpBAK-7q were centrifuged overnight at 48,000 x g. The resulting pellet was resuspended in urea to remove soluble proteins, and the recombinant antigen was recovered by further centrifugation at 230,000 x g. After washing with Triton X-100, the partially purified protein was dissolved in SDS and 3-mercaptoethanol and further purified by gel filtration in the presence of SDS-13-mercaptoethanol. During the purification procedure, the antigen was monitored by SDS-PAGE, and Fig. 7 shows analysis of the final gel filtration fractions. Western blot analysis identified the 19-kDa antigen in fractions 27 to 32 (Fig. 7B) . Similarly, ConA binding and T-cell reactivity were localized in precisely the same column fractions (Fig. 7C and D) . Interestingly, although gel filtration was carried out under denaturing conditions, the 19-kDa antigen did not elute along with other similar-sized proteins from the column (Fig. 7A) (16) . Final proof of the glycoprotein nature of mycobacterial antigens will require chemical demonstration of a covalent carbohydrate-peptide interaction, and the availability of the defined recombinant system described here for the 19-kDa antigen will be particularly useful in pursuing such investigations.
We do not know whether posttranslational modification of the 19-kDa antigen affects its immunological activity. Monoclonal antibodies recognize both the M. smegmatis and E. coli recombinant antigens and are not apparently influenced by acylation or glycosylation. Similarly, the E. coli recom- 
